Retina Synthesis

Retina Synthesis

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Vizitează neapărat site-ul podcastului și susține-i creatorul: retinasynthesis.com

Autor

Retina Synthesis

Categorie

Education

Site-ul podcastului

retinasynthesis.com

Cel mai nou episod

14 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

A Post-Hoc Comparison of Syfovre and Izervay in Treatment of Geographic Atrophy 18.01.2024

We discuss a post-hoc study comparing the efficacy of Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) with Paul Hahn, MD, PhD, of NJ Retina.

4 Year Results from DRCR Network Protocol W 11.01.2024

We discuss a comparative trial of preventive therapy for non-proliferative retinopathy vs. ad hoc treatment of disease complications with Dr. Hani Salehi-Had of Retina Associates of Southern California, Huntington Beach, California.

Gene Therapy for X-Linked Retinitis Pigmentosa 04.01.2024

We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.

Optogenetic Therapy of Inherited Retinal Degenerations 21.12.2023

We discuss the use of optogenetics for the treatment of inherited retinal degenerations with Dr. Jose Sahel, Chairman and Distinguished Professor of Ophthalmology at the University of Pittsburgh School of Medicine.

A Real World Analysis of Aflibercept Therapy of Diabetic Macular Edema 14.12.2023

We discuss the importance of intensive therapy of DME, when using aflibercept for DME, as suggested by a review of real world cases from the Vestrum  data base, with Dr. Ferhina Ali, Assistant Professor of Ophthalmology, New York Medical College

Topical Therapy of Diabetic Macular Edema 07.12.2023

We discuss the use of a topical agent for the treatment of diabetic macular edema with Dr. Arshad Khanani, Director of Research, Sierra Eye Associates, Associate Clinical Professor of Ophthalmology, University Nevada School of Medicine, Reno.

Mitochrondial Therapy of Intermediate AMD 30.11.2023

We review novel approaches for the treatment of intermediate AMD, with Dr. Barry Kuppermann, Director Gavin Herbert Eye Institute, Chairman Department of Ophthalmology, University of California Irvine, Steinert Endowed Chair.

Safety Considerations in Retinal Gene Therapy 16.11.2023

 In our latest update, we discuss safety issues associated with retinal gene therapy with Professor Glenn Yiu of the University of California School of Medicine.

An Oral Agent for Treatment of Diabetic Retinopathy 09.11.2023

We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina Consultants, Springfield, MA

Intravitreal Gene Therapy with 4D-150 26.10.2023

We discuss intravitreal gene therapy with a new agent, 4D-150 with Veeral Sheth, MD, MBA  Assistant Clinical Professor of Ophthalmology University of Illinois at Chicago.

Optogenetics in the Treatment of Retinal Degenerations 19.10.2023

We discuss the use of optogenetics in the treatment of retinal degenerations with Dr. Michael Singer, Adjunct Professor of Ophthalmology, University of Texas Health Science Center, San Antonio.

Update on the Iluvien System for Treatment of Diabetic Macular Edema 12.10.2023

We discuss retinal drying in diabetic macular edema using the Iluvien implant with Dr. Michael Singer, Adjunct Professor, University of Texas Health Science Center, San Antonio.

The Ophthea Clinical Trial for Neovascular AMD 05.10.2023

We discuss the use of blockade of VEGF C and D in the treatment of neovascular AMD with Dr. Dante Pieramici, California Retina Research Foundation, California Retina Consultants.

Senolytic Therapy for Diabetic Macular Edema 28.09.2023

We discuss the use of a novel treatment approach, senolytic therapy, for the treatment of diabetic macular edema with Dr. David Boyer, Adjunct Professor, USC Roski Eye Institute.

The Port Delivery System for Treating Diabetic Retinopathy 21.09.2023

We discuss the use of the PDS in the treatment of diabetic retinopathy and diabetic macular edema with Professor Carl Regillo of the Wills Eye Hospital.

A Profile of Eugene de Juan, MD 14.09.2023

Dr. Eugene de Juan, winner of this year's ASRS Pyron Award, joins us to discuss his career highlights. Dr. de Juan is CEO of Forsight Labs and Professor of Ophthalmology, University of California, San Francisco.

An Implantation Telescope for Macular Disease 31.08.2023

We discuss the use of an improved implantable telescope as a low vision aid in patients with macular disease with Dr. David Almeida, Erie Retina Research.

Prevention of Vision Loss in the Gather Trial of IZERVAY 24.08.2023

We discuss the prevention of vision loss in the Gather 2 trial of IZERVAY with Dr. Carl Danzig of the Rand Eye Institute, Pompano Beach, Florida

GALE Long Term Extension Study for GA 14.08.2023

We discuss a 30-Month Outcome with Pegcetacoplan for the Treatment of Geographic Atrophy with Nathan Steinle MD, California Retina Consultants, Santa Barbara, California.

Pegcetacoplan (SYFOVRE) Clinical Update 11.08.2023

We discuss the latest information on Safety & Efficacy in Clinic and Clinical Trials with Cedric Francois, MD, PhD.

Faricimab in Neovascular AMD 03.08.2023

We discuss the latest information on the use of faricimab in neovascular AMD with Dr. Yasha Modi, Associate Professor of Ophthalmology, NYU Langone Medical Center.

High Dose Aflibercept for Neovascular AMD 27.07.2023

We discuss the use of high dose aflibercept for the treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor, Roski Eye Institute of USC.

Pegcetacoplan for Geographic Atrophy Update 20.07.2023

We discuss the latest information on the use of pegcetacoplan for geographic atrophy in AMD with Dr. Dilsher Dhoot, California Retinal Consultants.

Ocular Therapeutix: A TKI and Hydrogel Implant 13.07.2023

We discuss the use of a novel drug (tyrosine kinase inhibitor) and novel delivery system (hydrogel) for the treatment of neovascular AMD with Dr. Peter Kaiser of the Cleveland Clinic.

Biosimilar Drugs for Retinal Diseases 06.07.2023

We discuss the use of biosimilar drugs for retinal diseases with Dr. Arghavan Almony, author of definitive monograph of these agents.

Ascultă podcastul Retina Synthesis în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice